FDA Increases OTC Monograph User Fees by 19 Percent for Fiscal 2022 Post author:PacConAdmin Post published:March 14, 2022 Post category:Drug Industry Daily The FDA has released its over-the-counter (OTC) monograph drug user fees for fiscal 2022. Source: Drug Industry Daily You Might Also Like FTC Loses Challenge to Impax-Endo Opioid Agreement May 28, 2018 ANDAs Must Demonstrate “Sameness” of Active Ingredients, FDA Draft Guidance Says November 8, 2022 Biogen Settles Whistleblower Kickback Suit for $900 Million September 27, 2022